Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Surgical Wound Infection 1Prostatic Neoplasms 1Inflammatory Bowel Diseases 1Diverticulitis 1

Interventions

Infliximab 5Tea 3Polyethylene Glycols 3Blood Specimen Collection 3Standard of Care 2MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Colonoscopy 2CT-P13 2Biopsy 2Adalimumab 2sodium phosphate 1purine 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1fumaric acid 1cabozantinib 1Tumor Necrosis Factor Inhibitors 1Thrombin Time 1Surveys and Questionnaires 1Surgical Tape 1Sulfasalazine 1Spectrum Analysis, Raman 1Specimen Handling 1Single-Balloon Enteroscopy 1Registries 1Proctocolectomy, Restorative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Bowel Diseases × Benchmarking × Clear all
NCT03042091 2018-08-22

Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery

Thomas Jefferson University

Phase EARLY_PHASE1 Unknown
224 enrolled
Gastrointestinal

Diverticulitis, Surgical Wound Infection, Colorectal Neoplasms, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡